C49 NO CONTRAST TAVI

نویسندگان

چکیده

Abstract Background Chronic renal failure is a common comorbidity in patients undergoing TAVI. Large amounts of contrast media are generally needed to safely perform TAVI with potential deleterious effects on function and long term life quality. Objectives Every step the procedure can be replaced by no techniques: ultrasound guided vascular puncture final check, alignement 3 guides Valsalva sinuses check coplanarity or cusp overlap, coupling hemodynamics transthoracic echocardiography results need postdilatation, measure gradient across arterial rule out iatrogenic stenosis. Matherials Methods severe (GFR < 30 ml/min/ 1.73 m2) 1 patient moderate previous double transplantation underwent protocol without our center last year. All cases were performed local anesthesia conscious sedation. balloon expandable bioprosthesis self bioprosthesis. Results We able all 4 which technique was attempted complications. Hemodynamics excellent residual significant leaks. No complication occured. Procedural time 20% longer than average but X rays dose exposure reduced because less cine acquisitions needed. Conclusions use feasible safe extensive ultrasound, hemodynamics, multiple depict coronary assure correct prothesis implantation.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Reduced contrast media volumes for CT imaging of TAVI candidates.

Pre-procedural computed tomography angiography (CTA) is currently becoming a gold standard for the evaluation of patients considered for transcatheter aortic valve implantation (TAVI)/ transcatheter aortic valve replacement (TAVR). The superiority of CTA-based over 2D transoesophageal echocardiography-based procedural planning is mainly explained by the improved outcomes with reduced rates of r...

متن کامل

Failed TAVI in TAVI Implantation: TAVI Dislocation Followed by Ensuing Surgical Graft Resection

We are presenting a case report of failed valve-in-valve treatment of severe aortic stenosis. A control ultrasonography after TAVI implantation revealed a severe aortic regurgitation of the graft which was subsequently unresolved with postimplantation dilatation. Second TAVI was implanted with cranial dislocation to the aortic root. Patient underwent a CT examination to clarify the TAVI in TAVI...

متن کامل

No Association between Gadolinium-Based Contrast Agents and Development of Nephrogenic Systemic Fibrosis: a Case Study

Nephrogenic systemic fibrosis (NSF), previously known as nephrogenic fibrosing dermopathy, is an emerging systemic fibrosing disorder that develops in the setting of renal insufficiency. Nephrogenic fibrosing dermopathy (NFD) is a fibrosing condition of the skin which shows an increased number of dendritic cells, fibroblasts and thickened collagen fibers resembling scleromyxedema. It is charact...

متن کامل

Antithrombotic therapy in TAVI

Transcatheter aortic valve implantation (TAVI) carries a significant thromboembolic and concomitant bleeding risk, not only during the procedure but also during the periprocedural period. Many issues concerning optimal antithrombotic therapy after TAVI are still under debate. In the present review, we aimed to identify all relevant studies evaluating antithrombotic therapeutic strategies in rel...

متن کامل

Population screening for TAVI procedure

Background Transcatheter aortic valve implantation (TAVI) is an alternative that offers hope to patients who are older, or have contraindication to conventional surgical aortic valve replacement due to considerable comorbidities. In our country there is about 500 to 1000 patients, older than 80 years needing this, less invasive procedure. The aim of this study was to asses the number of high-ri...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Heart Journal Supplements

سال: 2023

ISSN: ['1520-765X', '1554-2815']

DOI: https://doi.org/10.1093/eurheartjsupp/suad111.048